共 16 条
[1]
Biagini G., Pugnaloni A., Carboni V., Mazzanti L., Cester N., Romanini C., Toschi E., Castaldini C., Placental villidecidua interactions innormal and hypertensive pregnancies. A morphological quantitative study, Gynecol Obstet Invest, 34, pp. 15-19, (1992)
[2]
Kilpatrick D.C., Liston W.A., Gibson F., Livingstone J., Association between susceptibility to preeclampsia within families and HLA DR, Lancet, 335, pp. 660-661, (1990)
[3]
Kuhnert M., Strohmeier R., Yller M.S., Halberstad T., Changes in lymphocyte subpopulation during normal pregnancy, Eur J Obstet Gynecol Reprod Biol, 76, pp. 147-151, (1998)
[4]
Lin H., Mosmann T.R., Guilbert L., Tantipopipat S., Wegmann T.G., Synthesis of T helper 2-type cytokine at the maternal-fetal interface, J Immunol, 151, pp. 4562-4573, (1993)
[5]
Liu C.L., Xu H.Y., Liu Y., Serum level of soluble interleukin-2 receptor and T lymphocyte sub population in normal pregnancy, Chug Hua Ko Tsa Chih, 29, pp. 518-520, (1994)
[6]
Marinoni E., De Pita, Bresadola M., Ippoliti F., Dilorio R., Cell-mediated immunity imbalanced in pregnancy, induced hypertension, Gynecol Obstet Invest, 38, pp. 236-240, (1994)
[7]
Neefjes J.J., Ploegh H.L., Intracellular transport of MHC class II molecules, Immunol Today, 13, pp. 179-189, (1992)
[8]
Omu A.E., Al-Othman S., Al-Qattan F., Al-Falah F.Z., Sherma P., A comparative study of Obstetric outcome of patients with pregnancy induced hypertension: Economic considerations, Acta Obstet Gynecol, 75, pp. 443-448, (1996)
[9]
Omu A.E., Al-Qattan F., Bukhadour N., Human leukocyte antigens in pregnant women with preeclampsia associated with intrauterine growth retardation and in normal controls, Arch Gynecol Obstet, 261, pp. 129-137, (1998)
[10]
Omu A.E., Al-Qattan F., Diejomaoh M.E., Al-Yatama, Differential levels of T helper cytokines in preeclampsia: Pregnancy, labor and puerperium, Acta Obstet Gynecol Scand, 78, pp. 675-680, (1999)